Tumor cells

Thawing Protocol

Cell Line Catalog (Volume 2)

T8211 HT-29-C1.27H Cells

HT-29-Cl.27H Cells (T8211) by MBP are derived from colorectal adenocarcinoma and are less tumorigenic than the original tumor cells. Cancer derivatives of normal intestinal crypt stem cells, used for intestinal cell differentiation studies. Human colon, adherent epithelial-like. BSL II. 1&times;106 cells / 1.0 mL, frozen. MTA required.

T8212 HT29-C1.19A Cells

HT29-Cl.19A Cells (T8212) by MBP are derived from the HT29 colonic cancer line with transepithelial solute movement. Used for investigation of intestinal cell differentiation. Human colon, adherent epithelial-like. BSL II. 1&times;106 cells / 1.0 mL, frozen. MTA required.

T8213 HT29-C1.16E Cells

HT29-Cl.16E Cells (T8213) by MBP are derived from the HT29 colonic cancer line and contain 600 times more mucus than the original HT29 cells. Used for investigation of intestinal cell differentiation. Human (H. sapiens), colon, adherent epithelial-like. BSL II. 1&times;106 cells / 1.0 mL, frozen. MTA required.

T8214 SNU MM1393 BM Cells

T8214 SNU MM1393 BM Cells are a human multiple myeloma suspension cell line derived from NRG/SCID mouse bone marrow engraftment, tetraploid and IL-6-dependent, highly resistant to bortezomib. Supplied by ABM as 1&times;106 cells/1.0 ml, frozen; BSL-2; RUO. MTA required.

T8215 SNU MM1393 SC Cells

T8215 SNU MM1393 SC Cells are a human multiple myeloma suspension cell line derived from subcutaneous tumor in NRG/SCID mice, from the same 63-year-old male donor as SNU MM1393 BM (T8214). Supplied by ABM as 1&times;106 cells/1.0 ml, frozen; BSL-2; RUO. MTA required.

T8216 Tamoxifen-resistant MCF-7 (MCF-7/TAM1) Cells

T8216 MCF-7/TAM1 Cells are tamoxifen-resistant MCF-7 human breast adenocarcinoma cells capable of spheroid formation, used for endocrine therapy resistance and SERD research. Trypsin-sensitive; requires Ultra-Gentle Cell Detachment Solution. Supplied by ABM as 1&times;106 cells/1.0 ml, frozen; BSL-2; RUO. MTA required.

T8222 AMCPAC04 Cells

T8222 AMCPAC04 Cells are highly invasive human pancreatic ductal adenocarcinoma cells with KRAS mutation and DPC4 expression, derived from a 53-year-old male patient. Supplied by ABM as 1&times;106 cells/1.0 ml, frozen; BSL-2; RUO. MTA required.

T8225 JVE-109 Cells

T8225 by Applied Biological Materials (ABM) is the JVE-109 human colorectal cancer line from an 84-year-old female with confirmed BRAF and TP53 mutations. Cells grow adherent with ~50-hour doubling time at 9,000 cells/cm&sup2; seeding density in DMEM/F-12 + 15% FBS. Suited for BRAF-mutant CRC signaling, drug-response, and compound mutation studies.

T8232 WSU-DLCL Cells

WSU-DLCL Cells (T8232) by MBP are a multidrug resistant histiocytic lymphoma cell line with mature B-cell phenotype, high P-glycoprotein expression, and hypertetraploidy. Suspension growth in clumps. PDT 48–72h. Post-thaw care required. Research model for MDR gene and chemotherapy resistance. BSL II. 1&times;106 cells / 1.0 mL, frozen. MTA required.

T8241 CCOC-T Cells

CCOC-T Cells (T8241) by MBP are derived from clear cell odontogenic carcinoma — very slow growth but highly invasive; express odontogenic factors and EMT molecules. Culture at 33.0&deg;C; trypsin-sensitive — use Gentle Dissociation Solution (TM080). PDT 30–40h. BSL II. 1&times;106 cells / 1.0 mL, frozen. MTA required.

T8242 U251N Cells

U251N Cells (T8242) by MBP are PAX6 knockout neuronal tumor cells showing increased proliferation, colony formation, and resilience to H2O2 and chemotherapeutic drugs. Model for studying PAX6 tumor suppression. Human brain astrocytoma, adherent neuronal. BSL II. 1&times;106 cells / 1.0 mL, frozen. MTA required.

T8248 HOVTAX2 Cells

T8248 HOVTAX2 Cells are a human high-grade serous papillary ovarian carcinoma cell line expressing ER receptors and tumorigenic in athymic nude mice. Supplied by ABM as 1&times;106 cells/1.0 ml, frozen; BSL-2; RUO. MTA required.